NIH-funded research R01 grant

Understanding how a key enzyme regulates protein functions in cells

Official title: Structural insights into the functional regulation of O-GlcNAcase

Funded at University of Wisconsin-Madison · NIH-11032860 · Data updated 2026-11-12

This study is looking at a special enzyme called O-GlcNAcase, which helps change proteins in our cells, to understand how it works and how it might be linked to diseases like cancer and neurodegeneration, with the hope that this knowledge could lead to better treatments for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startFebruary 15, 2024
Project endDecember 31, 2027
Funding year2025
Award (this year)$295,577
NIH project number5R01GM152998-02
Project IDNIH-11032860 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by cancers or neurodegenerative diseases linked to OGA dysfunction.

Less likely to help

Patients with conditions unrelated to OGA or those not affected by cancer or neurodegeneration may not benefit from this research.

What this research studies

This research focuses on the enzyme O-GlcNAcase (OGA), which plays a crucial role in modifying proteins within cells. By investigating the structure and function of OGA, the research aims to uncover how it interacts with various protein substrates, particularly in the context of diseases like cancer and neurodegeneration. The study employs advanced structural biology techniques to reveal the enzyme's binding mechanisms and regulatory roles, which could lead to new therapeutic strategies. Patients may benefit from insights gained about OGA's role in disease progression and treatment.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective and safer therapies for diseases associated with OGA dysfunction.

How similar studies have gone: Other research has shown promising results in targeting similar enzymes for therapeutic purposes, indicating a potential for success in this area.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Jiang, Jiaoyang — University of Wisconsin-Madison
  • Study coordinator: Jiang, Jiaoyang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.